Wilms' tumor natural history, complications and prognosis

Revision as of 15:32, 26 August 2015 by Shanshan Cen (talk | contribs)
Jump to navigation Jump to search

Wilms' tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wilms' Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wilms' tumor natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilms' tumor natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilms' tumor natural history, complications and prognosis

CDC on Wilms' tumor natural history, complications and prognosis

Wilms' tumor natural history, complications and prognosis in the news

Blogs on Wilms' tumor natural history, complications and prognosis

Directions to Hospitals Treating Wilms' tumor

Risk calculators and risk factors for Wilms' tumor natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Natural History

Complications

The tumor may become quite large, but usually remains self-enclosed. Spread of the tumor to the lungs, liver, bone, or brain is the most worrisome complication.

High blood pressure and kidney damage may occur as the result of the tumor or its treatment.

Removal of Wilms tumor from both kidneys may affect kidney function.

Prognosis

It is highly responsive to treatment, with about 90% of patients surviving at least five years with appropriate treatment.


Patients with mutations in chromosomes 1q, 11q and 16q have a worse prognosis than those without these mutations.

Survivors of this tumor are at risk for future malignancies especially leukemias and sarcomas arising either due to germline mutations or mutations acquired due to therapy for the primary tumor(Wilms’ tumor).

References

Template:WH Template:WS